Signaling Pathways in Cancer Symposium 2012

Understanding Signaling Pathways in Cancer

Tuesday, November 6, 2012

Speakers

Joan Brugge
Harvard Medical School

“Matrix Dependent Rewiring of Signaling Pathways Following
Targeted Therapies”

view video


Lewis Cantley
Harvard Medical School

“PI 3-Kinase and Cancer Metabolism”


Michael Comb
Cell Signaling Technology

“Mapping Signaling Networks in Cancer: Phosphorylation and Beyond”

view video


Rudolf Jaenisch
Whitehead Institute

“Stem Cells, Pluripotency and Nuclear Reprogramming”

view video

William Kaelin
Dana Farber Cancer Institute

“The VHL Tumor Suppressor Protein: Insights into Oxygen Sensing and Cancer Metabolism”

view video

Douglas Lauffenburger
MIT Dept. of Biological Engineering

“Multi-Scale In Vivo Systems Analysis of Cell Signaling in
Inflammatory Pathologies”

 view video

Rune Linding
Technical University of Denmark

“Biological Forecasting and Modeling of Cancer Kinome Networks”

view video

Benjamin Neel
University Health Network

“A New Role For Gab Proteins In Control Of Cell Polarity”

view video

David Sabatini
Whitehead Institute

“Growth By The mTOR Pathway”

view video

Jeffrey Settleman
Genentech, Inc.

“The Many Flavors of Resistance To Anti-Cancer Drugs”

view video

Forest White,
David H. Koch Institute for Integrative Cancer Research at MIT

“Connecting Genetics To Phenotype Through Quantitative Proteomics”

view video

Michael Yaffe
David H. Koch Institute for Integrative Cancer Research at MIT

“Harnessing Cross-Talk Between Signaling Pathways to Improve
Cancer Treatment”

view video